Birgitte Volck
Director/Board Member bij SOLENO THERAPEUTICS, INC.
Vermogen: 301 526 $ op 31-03-2024
Profiel
Momenteel bekleedt Birgitte Volck de functie van SVP, Head-Clinical Development & Medical Affairs bij Ascendis Pharma A. Dr. Volck is ook lid van de raad van bestuur van Soleno Therapeutics, Inc. en Vaccibody AS. Dr. Volck bekleedde voordien de volgende functies: Head-Research & Development bij GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bij Swedish Orphan Biovitrum AB, President-Research & Development bij Avrobio, Inc., Director-Executive Development bij Amgen, Inc., Director-Nordic Medical & Project Director bij Genzyme Danmark en Head-Clinical Development & Medical Affairs bij Pharmexa A. Birgitte Volck behaalde een doctoraat aan de Universiteit van Kopenhagen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0.02% | 26-05-2023 | 7 045 ( 0.02% ) | 301 526 $ | 31-03-2024 |
Actieve functies van Birgitte Volck
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 10-06-2019 |
| NYKODE THERAPEUTICS | Director/Board Member | 05-05-2021 |
Eerdere bekende functies van Birgitte Volck
| Bedrijven | Functie | Einde |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 01-12-2023 |
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 01-10-2020 |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 01-01-2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01-08-2018 |
| WILSON THERAPEUTICS AB | Director/Board Member | 01-05-2018 |
Opleiding van Birgitte Volck
| University of Copenhagen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 7 |
|---|---|
| AMGEN INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
| Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
